ENTITY
Shenzhen New Industries Biomedical Engineering-A

Shenzhen New Industries Biomedical Engineering-A (300832 CH)

24
Analysis
Health CareChina
Shenzhen New Industries Biomedical Engineering Co., Ltd. operates as a biomedical company. The Company researches, develops, produces, and sells clinical laboratory instrument and vitro diagnostic reagent. Shenzhen New Industries Biomedical Engineering also offers related technical service.
more
Refresh

CSI300 Index Rebalance Preview: Potential Adds Outperforming Despite ETF Inflows

The adds have outperformed the deleted by over 10% in the last month. Coming up to the end of the review period, there could be further positioning.

Logo
834 Views
Share
09 Apr 2024 15:57

Quiddity Leaderboard CSI 300/​​500 Jun 24: SHORTs Down 11% Vs Index Since Mid-Feb; Change the Hedge

I estimate one-way flows of US$1.45bn for the CSI 300 rebalance and US$2.35bn for the CSI 500 rebalance in June 2024. These estimates could still...

Share
11 Mar 2024 18:39

Quiddity Leaderboard CSI 300/​​500 Jun 24: Exp. One-Way Flow Tops US$3bn Due to Passive AUM Surge

Significant amounts of new passive money has flowed into the CSI 300 and CSI 500 index resulting in a sharp increase in our one-way flow...

Share
bullishZOZO Inc
10 Mar 2024 05:50

Index Rebalance & ETF Flow Recap: NKY, ASX, CSI300, A50, STTF, LowVol30, Value Up

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
807 Views
Share
14 Feb 2024 17:01

Quiddity Leaderboard CSI 300/​​500 Jun 24: SHORT CSI 300 Direct DELs Vs the Index

There could be one-way index flows of US$2.5bn collectively for the CSI 300 index and CSI 500 index in June 2024. The CSI 300 Direct DELs could...

Share
x